Endocrinology AdvisorChildhood Obesity Tied to Cardiometabolic Disease at Age 30 Years

ℹ️ Observational Association-Only Evidence

A 42,911-patient Swedish cohort found children with metabolically healthy obesity still face dramatically elevated cardiometabolic risk by age 30. MHO is not a low-risk phenotype, and weight reduction lowered risk equally in MHO and MUO groups.

Clinical Considerations

• By age 30, children with MHO had 9.1% type 2 diabetes incidence vs. 0.5% in the general population, an 18-fold difference.
• Hypertension reached 10.8% and dyslipidemia 5.3% in the MHO group, both substantially higher than general population peers.
• A BMI z-score reduction of 0.25 or more cut type 2 diabetes risk by 78% and produced similar benefit regardless of baseline metabolic status.
• Degree of obesity drove mortality risk more than metabolic status, with class II/III obesity showing a 5.5-fold higher mortality IRR.

Practice Applications

• Recognize that absent metabolic markers do not identify low-risk pediatric obesity in this cohort.
• Consider obesity treatment for children with obesity regardless of baseline lipid, glucose, or blood pressure findings.
• Integrate modest weight reduction goals, since a 0.25 BMI z-score drop was associated with meaningful long-term risk reduction.
• Monitor MHO patients longitudinally, as the phenotype is transient and progression to MUO is common.

More in Obesity/Weight Management